Targets and mechanisms for the regulation of translation in malignant transformation

Oncogene

Volumn 23, Issue 18, 2004, Pages 3180-3188

  Clemens, Michael J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

eIF2; eIF4E binding proteins; Oncogenic viruses; p53; PKR; TNF family

Indexed keywords

BINDING PROTEIN; CYTOKINE; GROWTH INHIBITOR; INITIATION FACTOR; INITIATION FACTOR 4E; INITIATION FACTOR 4G; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE; POLYPEPTIDE; PROTEIN KINASE; PROTEIN P53; RAPAMYCIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; EIF4EBP1 PROTEIN, HUMAN; INITIATION FACTOR 2; PHOSPHOPROTEIN; PROTEIN KINASE R; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

CARCINOGENESIS; CATALYSIS; CATALYST; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; RIBOSOME; RNA TRANSLATION; TRANSLATION REGULATION; TUMOR SUPPRESSOR GENE; VIRUS GENE; ANIMAL; APOPTOSIS; GENETICS; PHYSIOLOGY; PROTEIN SYNTHESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTOR-4E; EUKARYOTIC INITIATION FACTOR-4G; HUMANS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2342641580     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207544     Document Type: Review

References (107)

1. Abraham N, Jaramillo ML, Duncan PI, Metéthot N, Icely PL, Stojdl DF, Barber GN and Bell JC. (1998). Exp. Cell Res., 244, 394-404.
2. Appella E. (2001). Eur. J. Biochem., 268, 2763.
3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest, 104, 155-162.
4. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K and Barber GN. (1998). EMBO J., 17, 6888-6902.
5. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR and Barber GN. (2000). J. Virol., 74, 1513-1523.
6. Barber GN, Jagus R, Meurs EF, Hovanessian AG and Katze MG. (1995). J. Biol. Chem., 270, 17423-17428.
7. Baud V and Karin M. (2001). Trends Cell Biol., 11, 372-377.
8. Bauer C, Diesinger I, Brass N, Steinhart H, Iro H and Meese EU. (2001). Cancer, 92, 822-829.
9. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW and Meese E. (1997). Hum. Mol. Genet., 6, 33-39.
10. Budihardjo I, Oliver H, Lutter M, Luo X and Wang XD. (1999). Annu. Rev. Cell Dev. Biol., 15, 269-290.
11. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-223.
12. Carter PS, Jarquin-Pardo M and De Benedetti A. (1999). Oncogene, 18, 4326-4335.
13. Chacko MS and Adamo ML. (2002). Endocrinology, 143, 525-534.
14. Chung J, Bachelder RE, Lipscomb EA, Shaw LM and Mercurio AM. (2002). J. Cell Biol., 158, 165-174.
15. Clemens M. (1992). Nature, 360, 210-211.
16. Clemens MJ. (2001). Signaling Pathways for Translation. Progress in Molecular and Subcellular Biology, Vol. 27. Rhoads RE (ed). Springer: Berlin, pp. 57-89.
17. Clemens MJ and Bommer UA. (1999). Int. J. Biochem. Cell Biol., 31, 1-23.
18. Clemens MJ, Bushell M, Jeffrey IW, Pain VM and Morley SJ. (2000). Cell Death Differ., 7, 603-615.
19. Clemens MJ and Elia A. (1997). J. Interferon Cytokine Res., 17, 503-524.
20. Constantinou C, Bushell M, Jeffrey IW, Tilleray V, West M, Frost V, Hensold J and Clemens MJ. (2003). Eur. J. Biochem., 270, 3122-3132.
21. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S and Williams BRG. (2001). EMBO J., 20, 2487-2496.
22. Der SD, Yang YL, Weissmann C and Williams BRG. (1997). Proc. Natl. Acad. Sci. USA, 94, 3279-3283.
23. Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC and Houghton PJ. (2002). J. Biol. Chem., 277, 13907-13917.
24. Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N. (1995). EMBO J., 14, 3828-3834.
25. Evan G and Littlewood T. (1998). Science, 281, 1317-1322.
26. Ewen ME and Miller SJ. (1996). Biochim. Biophys. Acta, 1242, 181-184.
27. Ewen ME, Oliver CJ, Sluss HK, Miller SJ and Peeper DS. (1995). Genes Dev., 9, 204-217.
28. Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA and Thompson CB. (2003). Genes Dev., 17, 1841-1854.
29. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H and Igarashi K. (1997). Cancer Res., 57, 5041-5044.
30. Galy B, Creancier L, Prado-Lourenco L, Prats A-C and Prats H. (2001a). Oncogene, 20, 4613-4620.
31. Galy B, Créancier L, Zanibellato C, Prats AC and Prats H. (2001b). Oncogene, 20, 1669-1677.
32. Gao C and Tsuchida N. (1999). Jpn. J. Cancer Res., 90, 180-187.
33. Garcia MA, Guerra S, Gil J, Jimenez V and Esteban M. (2002). Oncogene, 21, 8379-8387.
34. Gil J and Esteban M. (2000). Oncogene, 19, 3665-3674.
35. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R and Sonenberg N. (1999a). Genes Dev., 13, 1422-1437.
36. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R and Sonenberg N. (2001a). Genes Dev., 15, 2852-2864.
37. Gingras AC, Raught B and Sonenberg N. (1999b). Annu. Rev. Biochem., 68, 913-963.
38. Gingras AC, Raught B and Sonenberg N. (2001b). Genes Dev., 15, 807-826.
39. Graff JR, De Benedetti A, Olson JW, Tamez P, Casero Jr RA and Zimmer SG. (1997). Biochem. Biophys. Res. Commun., 240, 15-20.
40. Graff JR and Zimmer SG. (2003). Clin. Exp. Metast., 20, 265-273.
41. Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M and Radosevich JA. (1996). Tumour Biol., 17, 5-12.
42. Hidalgo M and Rowinsky EK. (2000). Oncogene, 19, 6680-6686.
43. Horton LE, Bushell M, Barth-Baus D, Tilleray VJ, Clemens MJ and Hensold J. (2002). Oncogene, 21, 5325-5334.
44. Jagus R, Joshi B and Barber GN. (1999). Int. J. Biochem. Cell Biol., 31, 123-138.
45. Jeffrey IW, Bushell M, Tilleray VJ, Morley S and Clemens MJ. (2002). Cancer Res., 62, 2272-2280.
46. Jiang H, Coleman J, Miskimins R and Miskimins WK. (2003). Cancer Cell Int., 3, 2.
47. Kim SH, Forman AP, Mathews MB and Gunnery S. (2000). Oncogene, 19, 3086-3094.
48. Kim SH, Gunnery S, Choe JK and Mathews MB. (2002). Oncogene, 21, 8741-8748.
49. Kiyosawa K, Tanaka E and Sodeyama T. (1998). Curr. Stud. Hematol Blood Transfus., 62, 161-180.
50. Kokontis JM, Wagner AJ, O'Leary M, Liao S and Hay N. (2001). Oncogene, 20, 659-668.
51. Komano J, Maruo S, Kurozumi K, Oda T and Takada K. (1999). J. Virol., 73, 9827-9831.
52. Kozak M. (1991a). J. Cell Biol. 115, 887-903.
53. Kozak M. (1991b). J. Biol. Chem., 266, 19867-19870.
54. Laing KG, Elia A, Jeffrey I, Matys V, Tilleray VJ, Souberbielle B and Clemens MJ. (2002). Virology, 297, 253-269.
55. Li SN, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA and Bitterman PB. (2002). Mol. Cell. Biol., 22, 2853-2861.
56. Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA. (2003). J. Biol. Chem., 278, 3015-3022.
57. Lobo MVT, Martín ME, Pérez MI, Alonso FJM, Redondo C, Alvarez MI and Salinas M. (2000). Histochem. J., 32, 139-150.
58. Marchenko ND, Zaika A and Moll UM. (2000). J. Biol. Chem., 275, 16202-16212.
59. Marth JD, Overell RW, Meier KE, Krebs EG and Perlmutter RM. (1988). Nature, 332, 171-173.
60. Meijer HA and Thomas AAM. (2002). Biochem. J., 367, 1-11.
61. Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG. (1993). Proc. Natl. Acad. Sci. USA, 90, 232-236.
62. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and MoU UM. (2003). Mol. Cell, 11, 577-590.
63. Miller SJ, Suthiphongchai T, Zambetti GP and Ewen ME. (2000). Mol. Cell. Biol., 20, 8420-8431.
64. Morley SJ, Jeffrey I, Bushell M, Pain VM and Clemens MJ. (2000). FEBS Lett., 477, 229-236.
65. Morley SJ, McKendrick L and Bushell M. (1998). FEBS Lett., 438, 41-48.
66. Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F and Deppert W. (1995). EMBO J., 14, 4442-4449.
67. Nanbo A, Inoue K, Adachi-Takasawa K and Takada K. (2002). EMBO J., 21, 954-965.
68. Nicholson KM and Anderson NG. (2002). Cell. Signal., 14, 381-395.
69. Nomura M, He Z, Koyama I, Ma WY, Miyamoto K and Dong Z. (2003). Mol. Carcinogen., 38, 25-32.
70. Nussbaum JM, Major M and Gunnery S. (2003). Cancer Lett., 196, 207-216.
71. Packham G, Porter CW and Cleveland JL. (1996). Oncogene, 13, 461-469.
72. Parker LM, Fierro-Monti I and Mathews MB. (2001). J. Biol. Chem., 276, 32522-32530.
73. Patel RC and Sen GC. (1998). EMBO J., 17, 4379-4390.
74. Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC and Bitterman PB. (2000). J. Biol. Chem., 275, 24776-24780.
75. Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB. (1996). Mol. Cell. Biol., 16, 6573-6581.
76. Prendergast GC. (1999). Oncogene, 18, 2967-2987.
77. Rau M, Ohlmann T, Morley SJ and Pain VM. (1996). J. Biol. Chem., 271, 8983-8990.
78. Raught B, Gingras AC and Sonenberg N. (2001). Proc. Natl. Acad. Sci. USA, 98, 7037-7044.
79. Raveh T, Hovanessian AG, Meurs EF, Sonenberg N and Kimchi A. (1996). J. Biol. Chem., 271, 25479-25484.
80. Rosenwald IB. (1996a). Bioessays, 18, 243-250.
81. Rosenwald IB. (1996b). Cancer Lett., 102, 113-123.
82. Rosenwald IB, Hutzler MJ, Wang ST, Savas L and Fraire AE. (2001). Cancer, 92, 2164-2171.
83. Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ and Schmidt EV. (1993). Proc. Natl. Acad. Sci. USA, 90, 6175-6178.
84. Ruf IK, Rhyne PW, Yang CY, Cleveland JL and Sample JT. (2000). J. Virol., 74, 10223-10228.
85. Ryan KM, Phillips AC and Vousden KH. (2001). Curr. Opin. Cell Biol., 13, 332-337.
86. Saelens X, Kalai M and Vandenabeele P. (2001). J. Biol. Chem., 276, 41620-41628.
87. Salaün P, Pyronnet S, Morales J, Mulner-Lorillon O, Bellé R, Sonenberg N and Cormier P. (2003). Dev. Biol., 255, 428-439.
88. Savinova O, Joshi B and Jagus R. (1999). Int. J. Biochem. Cell Biol., 31, 175-189.
89. Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, Proud CG, Hilse K and Clemens MJ. (1993). Nucleic Acids Res., 21, 4483-4490.
90. Sonenberg N. (1994). Biochimie, 76, 839-846.
91. Srivastava SP, Kumar KU and Kaufman RJ. (1998). J. Biol. Chem., 273, 2416-2423.
92. Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V. (2000). Oncogene, 19, 1437-1447.
93. Taylor DR, Shi ST and Lai MMC. (2000). Microbe. Infect., 2, 1743-1756.
94. Tee AR and Proud CG. (2000). Oncogene, 19, 3021-3031.
95. Tokino T and Nakamura Y. (2000). Crit. Rev. Oncol. Hematol., 33, 1-6.
96. von der Haar T and McCarthy JE. (2002). Mol. Microbiol., 46, 531-544.
97. Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia WY, Chiao P, Ellis LM, Hung MC, Swisher SG and Hunt KK. (2002). Oncogene, 21, 6278-6288.
98. Vousden KH. (2000). Cell, 103, 691-694.
99. Vyas J, Elia A and Clemens MJ. (2003). RNA, 9, 858-870.
100. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
101. Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safran MS, Patwardhan NA and Khan A. (2001). Thyroid, 11, 1101-1107.
102. Wang ST, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA. (1999). Am. J. Pathol., 155, 247-255.
103. Williams BRG. (1999). Oncogens, 18, 6112-6120.
104. Yamamoto N, Takizawa T, Iwanaga Y and Shimizu N. (2000). FEBS Lett., 484, 153-158.
105. Young LS and Murray PG. (2003). Oncogene, 22, 5108-5121.
106. Zamanian-Daryoush M, Der SD and Williams BRG. (1999). Oncogene, 18, 315-326.
107. Zimmer SG, DeBenedetti A and Graff JR. (2000). Anticancer Res., 20, 1343-1351.